Lifetime exposure to brominated trihalomethanes in drinking water and swimming pool attendance are associated with chronic lymphocytic leukemia: a Multicase-Control Study in Spain (MCC-Spain).

Cancer Chronic lymphocytic leukemia Nitrate Trihalomethanes Water contaminants swimming pools

Journal

Journal of exposure science & environmental epidemiology
ISSN: 1559-064X
Titre abrégé: J Expo Sci Environ Epidemiol
Pays: United States
ID NLM: 101262796

Informations de publication

Date de publication:
19 Sep 2023
Historique:
received: 04 04 2023
accepted: 23 08 2023
revised: 22 08 2023
pubmed: 20 9 2023
medline: 20 9 2023
entrez: 19 9 2023
Statut: aheadofprint

Résumé

Chronic lymphocytic leukemia (CLL) etiology is poorly understood, and carcinogenic chemicals in drinking and recreational water are candidates. To evaluate the association between drinking-water exposure to trihalomethanes (THMs) and nitrate as well as lifetime swimming pool attendance and CLL. During 2010-2013, hospital-based CLL cases and population-based controls were recruited in Spain, providing information on residential histories, type of water consumed and swimming pool attendance. Average THMs and nitrate levels in drinking water were linked to lifetime water consumption. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using mixed models. Final samples for residential tap water analyses and swimming pool attendance analyses were 144 cases/1230 controls and 157 cases/1240 controls, respectively. Mean (SD) values for average lifetime residential brominated THMs and chloroform in tap water (μg/L), and ingested nitrate (mg/day) were 48.1 (35.6), 18.5 (6.7) and 13.7 (9.6) respectively in controls; and 72.9 (40.7), 17.9 (5.4), and 14.1 (8.8) in CLL cases. For each 10 μg/L increase of brominated THMs and chloroform lifetime-average levels, the ORs (95% CI) were 1.22 (1.14, 1.31) and 0.54 (0.34, 0.87), respectively. For each 5 mg/day increase of ingested nitrate, the OR of CLL was 0.91 (0.80, 1.04). The OR of lifetime pool users (vs. non-users) was 2.38 (1.61, 3.52). Upon performing annual frequency of attending pools analysis through categorization, the second and third categories showed an ORs of 2.36 (1.49, 3.72) and 2.40 (1.51, 3.83), respectively, and P-trend of 0.001. This study identifies an association of long-term exposure to THMs in drinking water, at concentrations below the regulatory thresholds and WHO guidelines, and swimming pool attendance, with chronic lymphocytic leukemia (CLL). These unprecedented findings are highly relevant since CLL is an incurable cancer with still unknown etiology and because the widespread exposure to chlorination by-products that remain in drinking and recreational water worldwide. Despite the demonstrated carcinogenicity in animals of several chlorination by-products, little is known about their potential risks on human health. This study makes a significant contribution to the search for environmental factors involved in the etiology of CLL and to the evidence of the health impact of these high prevalent water contaminants.

Sections du résumé

BACKGROUND BACKGROUND
Chronic lymphocytic leukemia (CLL) etiology is poorly understood, and carcinogenic chemicals in drinking and recreational water are candidates.
OBJECTIVE OBJECTIVE
To evaluate the association between drinking-water exposure to trihalomethanes (THMs) and nitrate as well as lifetime swimming pool attendance and CLL.
METHODS METHODS
During 2010-2013, hospital-based CLL cases and population-based controls were recruited in Spain, providing information on residential histories, type of water consumed and swimming pool attendance. Average THMs and nitrate levels in drinking water were linked to lifetime water consumption. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using mixed models.
RESULTS RESULTS
Final samples for residential tap water analyses and swimming pool attendance analyses were 144 cases/1230 controls and 157 cases/1240 controls, respectively. Mean (SD) values for average lifetime residential brominated THMs and chloroform in tap water (μg/L), and ingested nitrate (mg/day) were 48.1 (35.6), 18.5 (6.7) and 13.7 (9.6) respectively in controls; and 72.9 (40.7), 17.9 (5.4), and 14.1 (8.8) in CLL cases. For each 10 μg/L increase of brominated THMs and chloroform lifetime-average levels, the ORs (95% CI) were 1.22 (1.14, 1.31) and 0.54 (0.34, 0.87), respectively. For each 5 mg/day increase of ingested nitrate, the OR of CLL was 0.91 (0.80, 1.04). The OR of lifetime pool users (vs. non-users) was 2.38 (1.61, 3.52). Upon performing annual frequency of attending pools analysis through categorization, the second and third categories showed an ORs of 2.36 (1.49, 3.72) and 2.40 (1.51, 3.83), respectively, and P-trend of 0.001.
IMPACT STATEMENT UNASSIGNED
This study identifies an association of long-term exposure to THMs in drinking water, at concentrations below the regulatory thresholds and WHO guidelines, and swimming pool attendance, with chronic lymphocytic leukemia (CLL). These unprecedented findings are highly relevant since CLL is an incurable cancer with still unknown etiology and because the widespread exposure to chlorination by-products that remain in drinking and recreational water worldwide. Despite the demonstrated carcinogenicity in animals of several chlorination by-products, little is known about their potential risks on human health. This study makes a significant contribution to the search for environmental factors involved in the etiology of CLL and to the evidence of the health impact of these high prevalent water contaminants.

Identifiants

pubmed: 37726507
doi: 10.1038/s41370-023-00600-7
pii: 10.1038/s41370-023-00600-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.
pubmed: 26980727 pmcid: 4874220 doi: 10.1182/blood-2016-01-643569
NIH. The Surveillance Epidemiology and End Results (SEER) Program of the National Cancer Institute Cancer fact sheets: chronic lymphocytic leukemia (CLL) https://seer.cancer.gov/statfacts/html/clyl.html (Accessed 13th September 2023).
Yang SM, Li JY, Gale RP, Huang XJ. The mystery of chronic lymphocytic leukemia (CLL): why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology? Blood Rev. 2015;29:205–13.
pubmed: 25541495 doi: 10.1016/j.blre.2014.12.001
Benavente Y, Casabonne D, Costas L, Robles C, Alonso E, de la Banda E, et al. Established and suggested exposures on CLL/SLL etiology: results from the CLL-MCC-Spain study. Cancer Epidemiol. 2018;52:106–11.
pubmed: 29289901 doi: 10.1016/j.canep.2017.12.012
Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS, et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014:41–51.
pubmed: 25174025 pmcid: 4155456 doi: 10.1093/jncimonographs/lgu001
Richardson S, Thruston A, Caughran T, Chen P, Collette T, Schenck K, et al. Identification of new drinking water disinfection by-products from ozone, chlorine dioxide, chloramine, and chlorine. Water Air Soil Pollut. 2000;123:95–102.
doi: 10.1023/A:1005265509813
International Agency for Research on Cancer. IARC, monographs on the evaluation of carcinogenic risk to humans. In: Trichloroethylene, tetrachloroethylene, and some other chlorinated agents: Lyon, France: IARC; 2014.
Zare Afifi M, Blatchley ER 3rd. Seasonal dynamics of water and air chemistry in an indoor chlorinated swimming pool. Water Res. 2015;68:771–83.
pubmed: 25462781 doi: 10.1016/j.watres.2014.10.037
Ward MH, Jones RR, Brender JD, de Kok TM, Weyer PJ, Nolan BT, et al. Drinking water nitrate and human health: an updated review. Int J Environ Res Public Health. 2018;15:1557.
pubmed: 30041450 pmcid: 6068531 doi: 10.3390/ijerph15071557
Espejo-Herrera N, Gracia-Lavedan E, Pollan M, Aragones N, Boldo E, Perez-Gomez B, et al. Ingested nitrate and breast cancer in the Spanish Multicase-Control Study on Cancer (MCC-Spain). Environ Health Perspect. 2016;124:1042–9.
pubmed: 26942716 pmcid: 4937871 doi: 10.1289/ehp.1510334
Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Cogliano V, et al. Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol. 2006;7:628–9.
pubmed: 16900606 doi: 10.1016/S1470-2045(06)70789-6
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum. 2010;94:1–412.
Castano-Vinyals G, Aragones N, Perez-Gomez B, Martin V, Llorca J, Moreno V, et al. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac Sanit. 2015;29:308–15.
pubmed: 25613680 doi: 10.1016/j.gaceta.2014.12.003
Martin-Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodriguez JC, Salvini S, et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol. 1993;22:512–9.
pubmed: 8359969 doi: 10.1093/ije/22.3.512
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–56.
pubmed: 18216293 pmcid: 2972576 doi: 10.1182/blood-2007-06-093906
Croghan C, Egeghy PP. Methods of dealing with values below the limit of detection using SAS. St. Petersburg, FL: Southern SAS User Group; 2003.
Espejo-Herrera N, Kogevinas M, Castano-Vinyals G, Aragones N, Boldo E, Ardanaz E, et al. Nitrate and trace elements in municipal and bottled water in Spain. Gac Sanit. 2013;27:156–60.
pubmed: 22444517 doi: 10.1016/j.gaceta.2012.02.002
Font-Ribera L, Kogevinas M, Nieuwenhuijsen MJ, Grimalt JO, Villanueva CM. Patterns of water use and exposure to trihalomethanes among children in Spain. Environ Res. 2010;110:571–9.
pubmed: 20554274 doi: 10.1016/j.envres.2010.05.008
Villanueva CM, Kogevinas M, Grimalt JO. Haloacetic acids and trihalomethanes in finished drinking waters from heterogeneous sources. Water Res. 2003;37:953–8.
pubmed: 12531279 doi: 10.1016/S0043-1354(02)00411-6
International Agency for Research on Cancer, et al. IARC, Monographs on the Evaluation of Carcinogenic Risk to Humans. Some chemicals present in industrial and consumer products. Food and Drinking-Water Lyon (France). 2016;101:349–74.
Villanueva CM, Cordier S, Font-Ribera L, Salas LA, Levallois P. Overview of disinfection by-products and associated health effects. Curr Environ Health Rep. 2015;2:107–15.
pubmed: 26231245 doi: 10.1007/s40572-014-0032-x
Costet N, Villanueva CM, Jaakkola JJ, Kogevinas M, Cantor KP, King WD, et al. Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies. Occup Environ Med. 2011;68:379–85.
pubmed: 21389011 doi: 10.1136/oem.2010.062703
Save-Soderbergh M, Toljander J, Donat-Vargas C, Akesson A. Drinking water disinfection by-products and congenital malformations: a nationwide register-based prospective study. Environ Health Perspect. 2021;129:97012.
pubmed: 34585603 doi: 10.1289/EHP9122
Nieuwenhuijsen MJ, Martinez D, Grellier J, Bennett J, Best N, Iszatt N, et al. Chlorination disinfection by-products in drinking water and congenital anomalies: review and meta-analyses. Environ Health Perspect. 2009;117:1486–93.
pubmed: 20019896 pmcid: 2790500 doi: 10.1289/ehp.0900677
Villanueva CM, Font-Ribera L. Health impact of disinfection by-products in swimming pools. Ann Ist Super Sanita. 2012;48:387–96.
pubmed: 23247135 doi: 10.4415/ANN_12_04_06
Font-Ribera L, Marco E, Grimalt JO, Pastor S, Marcos R, Abramsson-Zetterberg L, et al. Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage - the PISCINA2 Study. Environ Int. 2019;131:104988.
pubmed: 31323486 doi: 10.1016/j.envint.2019.104988
Cortes C, Marcos R. Genotoxicity of disinfection byproducts and disinfected waters: a review of recent literature. Mutat Res Genet Toxicol Environ Mutagen. 2018;831:1–12.
pubmed: 29875071 doi: 10.1016/j.mrgentox.2018.04.005
Richardson SD, Plewa MJ, Wagner ED, Schoeny R, Demarini DM. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research. Mutat Res. 2007;636:178–242.
pubmed: 17980649 doi: 10.1016/j.mrrev.2007.09.001
de Castro Medeiros L, de Alencar FLS, Navoni JA, de Araujo ALC, do Amaral VS. Toxicological aspects of trihalomethanes: a systematic review. Environ Sci Pollut Res Int. 2019;26:5316–32.
pubmed: 30607849 doi: 10.1007/s11356-018-3949-z
Daniel FB, Reddy TV, Stober JA, Olson GR. Site-specific modulation of carcinogen-induced gastrointestinal tract nuclear anomalies in B6C3F1 mice by chloroform. Anticancer Res. 1991;11:665–70.
pubmed: 2064320
Zhang L, Cai Q, Lin J, Fang Y, Zhan Y, Shen A, et al. Chloroform fraction of Scutellaria barbata D. Don promotes apoptosis and suppresses proliferation in human colon cancer cells. Mol Med Rep. 2014;9:701–6.
pubmed: 24337216 doi: 10.3892/mmr.2013.1864
Plewa MJ, Muellner MG, Richardson SD, Fasano F, Buettner KM, Woo YT, et al. Occurrence, synthesis, and mammalian cell cytotoxicity and genotoxicity of haloacetamides: an emerging class of nitrogenous drinking water disinfection byproducts. Environ Sci Technol. 2008;42:955–61.
pubmed: 18323128 doi: 10.1021/es071754h
Ding S, Chu W, Krasner SW, Yu Y, Fang C, Xu B, et al. The stability of chlorinated, brominated, and iodinated haloacetamides in drinking water. Water Res. 2018;142:490–500.
pubmed: 29920459 doi: 10.1016/j.watres.2018.06.024
Allen JM, Plewa MJ, Wagner ED, Wei X, Bokenkamp K, Hur K, et al. Drivers of disinfection byproduct cytotoxicity in U.S. DRinking Water: Should Other DBPs be considered for regulation? Environ Sci Technol. 2022;56:392–402.
pubmed: 34910457 doi: 10.1021/acs.est.1c07998
Ashley DL, Blount BC, Singer PC, Depaz E, Wilkes C, Gordon S, et al. Changes in blood trihalomethane concentrations resulting from differences in water quality and water use activities. Arch Environ Occup Health. 2005;60:7–15.
pubmed: 16961003 doi: 10.3200/AEOH.60.1.7-15
Leavens TL, Blount BC, DeMarini DM, Madden MC, Valentine JL, Case MW, et al. Disposition of bromodichloromethane in humans following oral and dermal exposure. Toxicol Sci. 2007;99:432–45.
pubmed: 17656487 doi: 10.1093/toxsci/kfm190
Carter RAA, Allard S, Croue JP, Joll CA. Occurrence of disinfection by-products in swimming pools and the estimated resulting cytotoxicity. Sci Total Environ. 2019;664:851–64.
pubmed: 30769309 doi: 10.1016/j.scitotenv.2019.01.428
Richardson SD, DeMarini DM, Kogevinas M, Fernandez P, Marco E, Lourencetti C, et al. What’s in the pool? A comprehensive identification of disinfection by-products and assessment of mutagenicity of chlorinated and brominated swimming pool water. Environ Health Perspect. 2010;118:1523–30.
pubmed: 20833605 pmcid: 2974688 doi: 10.1289/ehp.1001965
Chu H, Nieuwenhuijsen MJ. Distribution and determinants of trihalomethane concentrations in indoor swimming pools. Occup Environ Med. 2002;59:243–7.
pubmed: 11934951 pmcid: 1740275 doi: 10.1136/oem.59.4.243
Font-Ribera L, Esplugues A, Ballester F, Martinez-Arguelles B, Tardon A, Freire C, et al. [Trihalomethanes in swimming pool water in four areas of Spain participating in the INMA project]. Gac Sanit. 2010;24:483–6.
pubmed: 21074293 doi: 10.1016/j.gaceta.2010.07.003
Carter RAA, Joll CA. Occurrence and formation of disinfection by-products in the swimming pool environment: A critical review. J Environ Sci. 2017;58:19–50.
doi: 10.1016/j.jes.2017.06.013
Kogevinas M, Villanueva CM, Font-Ribera L, Liviac D, Bustamante M, Espinoza F, et al. Genotoxic effects in swimmers exposed to disinfection by-products in indoor swimming pools. Environ Health Perspect. 2010;118:1531–7.
pubmed: 20833606 pmcid: 2974689 doi: 10.1289/ehp.1001959
Weaver WA, Li J, Wen Y, Johnston J, Blatchley MR, Blatchley ER 3rd. Volatile disinfection by-product analysis from chlorinated indoor swimming pools. Water Res. 2009;43:3308–18.
pubmed: 19501873 doi: 10.1016/j.watres.2009.04.035
Liberatore HK, Daiber EJ, Ravuri SA, Schmid JE, Richardson SD, DeMarini DM. Disinfection byproducts in chlorinated or brominated swimming pools and spas: role of brominated DBPs and association with mutagenicity. J Environ Sci. 2022;117:253–63.
doi: 10.1016/j.jes.2022.04.049
Jurado-Sanchez B, Ballesteros E, Gallego M. Screening of N-nitrosamines in tap and swimming pool waters using fast gas chromatography. J Sep Sci. 2010;33:610–6.
pubmed: 20127916 doi: 10.1002/jssc.200900679
Walse SS, Mitch WA. Nitrosamine carcinogens also swim in chlorinated pools. Environ Sci Technol. 2008;42:1032–7.
pubmed: 18351068 doi: 10.1021/es702301p
Egorov AI, Tereschenko AA, Altshul LM, Vartiainen T, Samsonov D, LaBrecque B, et al. Exposures to drinking water chlorination by-products in a Russian city. Int J Hyg Environ Health. 2003;206:539–51.
pubmed: 14626901 doi: 10.1078/1438-4639-00244
Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Vol. 3. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
Wei Y, Qiu X, Yazdi MD, Shtein A, Shi L, Yang J, et al. The impact of exposure measurement error on the estimated concentration-response relationship between long-term exposure to PM2.5 and mortality. Environ Health Perspect. 2022;130:77006.
pubmed: 35904519 doi: 10.1289/EHP10389

Auteurs

Carolina Donat-Vargas (C)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Cardiovascular and Nutritional Epidemiology, Intitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Manolis Kogevinas (M)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Yolanda Benavente (Y)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908, L'Hospitalet de Llobregat, Spain.

Laura Costas (L)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908, L'Hospitalet de Llobregat, Spain.

Elias Campo (E)

Haematopathology Section, Hospital Clınic of Barcelona, Institut d'Investigaciones Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Centrode Investigacion Biomedica en Red de Cancer (CIBERONC), Barcelona, Spain.

Gemma Castaño-Vinyals (G)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Guillermo Fernandez-Tardon (G)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Health Research Institute of Asturias, ISPA, Oviedo, Spain.

Javier Llorca (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Faculty of Medicine, University of Cantabria, Santander, Spain.

Inés Gómez-Acebo (I)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Faculty of Medicine, University of Cantabria, Santander, Spain.
IDIVAL. Instituto de Investigación Sanitaria Valdecilla, 39011, Santander, Spain.

Nuria Aragonés (N)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Marina Pollan (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Delphine Casabonne (D)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908, L'Hospitalet de Llobregat, Spain.

Cristina M Villanueva (CM)

ISGlobal, Barcelona, Spain. cristina.villanueva@isglobal.org.
Universitat Pompeu Fabra (UPF), Barcelona, Spain. cristina.villanueva@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. cristina.villanueva@isglobal.org.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. cristina.villanueva@isglobal.org.

Classifications MeSH